Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen
作者： A. Prat , J.S. Parker , C. Fan , M.C.U. Cheang , L.D. Miller
关键词:
摘要: … Four microarray datasets were combined and research-based versions of PAM50 intrinsic subtyping and risk of relapse (PAM50-ROR) score, 21-gene recurrence score (OncotypeDX), …
annalsofoncology.org
oup.com
paperity.org
oxfordjournals.org
researchgate.net 参考文章(32)
Aleix Prat, Matthew J. Ellis, Charles M. Perou, Practical implications of gene-expression-based assays for breast oncologists Nature Reviews Clinical Oncology. ,vol. 9, pp. 48- 57 ,(2012) , 10.1038/NRCLINONC.2011.178
Matthew J. Ellis, Vera J. Suman, Jeremy Hoog, Li Lin, Jacqueline Snider, Aleix Prat, Joel S. Parker, Jingqin Luo, Katherine DeSchryver, D. Craig Allred, Laura J. Esserman, Gary W. Unzeitig, Julie Margenthaler, Gildy V. Babiera, P. Kelly Marcom, Joseph M. Guenther, Mark A. Watson, Marilyn Leitch, Kelly Hunt, John A. Olson, Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031 Journal of Clinical Oncology. ,vol. 29, pp. 2342- 2349 ,(2011) , 10.1200/JCO.2010.31.6950
Charles M Perou, Joel S Parker, Aleix Prat, Matthew J Ellis, Philip S Bernard, Clinical implementation of the intrinsic subtypes of breast cancer. Lancet Oncology. ,vol. 11, pp. 718- 719 ,(2010) , 10.1016/S1470-2045(10)70176-5
Daniel S. Oh, Melissa A. Troester, Jerry Usary, Zhiyuan Hu, Xiaping He, Cheng Fan, Junyuan Wu, Lisa A. Carey, Charles M. Perou, Estrogen-Regulated Genes Predict Survival in Hormone Receptor–Positive Breast Cancers Journal of Clinical Oncology. ,vol. 24, pp. 1656- 1664 ,(2006) , 10.1200/JCO.2005.03.2755
Cheng Fan, Daniel S. Oh, Lodewyk Wessels, Britta Weigelt, Dimitry S.A. Nuyten, Andrew B. Nobel, Laura J. van't Veer, Charles M. Perou, Concordance among Gene-Expression–Based Predictors for Breast Cancer The New England Journal of Medicine. ,vol. 355, pp. 560- 569 ,(2006) , 10.1056/NEJMOA052933
Frank E. Harrell, Kerry L. Lee, Robert M. Califf, David B. Pryor, Robert A. Rosati, Regression modelling strategies for improved prognostic prediction. Statistics in Medicine. ,vol. 3, pp. 143- 152 ,(1984) , 10.1002/SIM.4780030207
Yi Zhang, Anieta M. Sieuwerts, Michelle McGreevy, Graham Casey, Tanja Cufer, Angelo Paradiso, Nadia Harbeck, Paul N. Span, David G. Hicks, Joseph Crowe, Raymond R. Tubbs, G. Thomas Budd, Joanne Lyons, Fred C. G. J. Sweep, Manfred Schmitt, Francesco Schittulli, Rastko Golouh, Dmitri Talantov, Yixin Wang, John A. Foekens, The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy Breast Cancer Research and Treatment. ,vol. 116, pp. 303- 309 ,(2009) , 10.1007/S10549-008-0183-2
Yudi Pawitan, Judith Bjöhle, Lukas Amler, Anna-Lena Borg, Suzanne Egyhazi, Per Hall, Xia Han, Lars Holmberg, Fei Huang, Sigrid Klaar, Edison T Liu, Lance Miller, Hans Nordgren, Alexander Ploner, Kerstin Sandelin, Peter M Shaw, Johanna Smeds, Lambert Skoog, Sara Wedrén, Jonas Bergh, None, Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Research. ,vol. 7, pp. 1- 12 ,(2005) , 10.1186/BCR1325
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park, William Hiller, Edwin R Fisher, D Lawrence Wickerham, John Bryant, Norman Wolmark, None, A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer The New England Journal of Medicine. ,vol. 351, pp. 2817- 2826 ,(2004) , 10.1056/NEJMOA041588
Kathy S Albain, William E Barlow, Steven Shak, Gabriel N Hortobagyi, Robert B Livingston, I-Tien Yeh, Peter Ravdin, Roberto Bugarini, Frederick L Baehner, Nancy E Davidson, George W Sledge, Eric P Winer, Clifford Hudis, James N Ingle, Edith A Perez, Kathleen I Pritchard, Lois Shepherd, Julie R Gralow, Carl Yoshizawa, D Craig Allred, C Kent Osborne, Daniel F Hayes, Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial Lancet Oncology. ,vol. 11, pp. 55- 65 ,(2010) , 10.1016/S1470-2045(09)70314-6